Utah Medical Products Inc
NASDAQ:UTMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Utah Medical Products Inc
Research & Development
Utah Medical Products Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Utah Medical Products Inc
NASDAQ:UTMD
|
Research & Development
-$577k
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-1%
|
|
|
Haemonetics Corp
NYSE:HAE
|
Research & Development
-$62.2m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-3%
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Research & Development
-$87.5m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-19%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Research & Development
-$369.9m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-20%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Research & Development
-$177.3m
|
CAGR 3-Years
17%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
-29%
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Research & Development
-$97.4m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-9%
|
|
Utah Medical Products Inc
Glance View
Utah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. The company is headquartered in Midvale, Utah and currently employs 178 full-time employees. UTMD’s products include Blood Monitoring, which includes Deltran Disposable Blood Pressure Transducers, Deltran Plus Arterial Blood Sampling Systems, and Deltran Accessories; Electrosurgery, which includes Epitome Electrosurgical Scalpels, OptiMicro Ultra-Fine Tip Electrosurgical Needles, Finesse+ Electrosurgical Generators, Filtresse Surgical Smoke Evacuation Systems and Finesse+ Accessories; Labor and Delivery, which includes AROM-Cot, BT-Cath, CVX-Ripe, Intran, Muc-X and Cordguard; Neonatal Intensive Care, which includes Hemo-Nate, Thora-Cath, Nutri-Cath, Nutri-Lok, Myelo-Nate, Disposa-Hood, Neonatal Deltran, Pala-Nate, PICC-Nate, Dialy-Nate, Umbili-Cath and Uri-Cath; Urological Care, which includes the Liberty, Supra-Foley, and Pathfinder Plus; Womens Pelvic Health, and original equipment manufacturer/Capabilities.
See Also
What is Utah Medical Products Inc's Research & Development?
Research & Development
-577k
USD
Based on the financial report for Sep 30, 2025, Utah Medical Products Inc's Research & Development amounts to -577k USD.
What is Utah Medical Products Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-1%
Over the last year, the Research & Development growth was 31%. The average annual Research & Development growth rates for Utah Medical Products Inc have been -4% over the past three years , -2% over the past five years , and -1% over the past ten years .
